000 01571 a2200409 4500
005 20250515041224.0
264 0 _c20061114
008 200611s 0 0 eng d
022 _a0889-8545
024 7 _a10.1016/j.ogc.2006.05.004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGris, Jean-Christophe
245 0 0 _aMonitoring the effects and managing the side effects of anticoagulation during pregnancy.
_h[electronic resource]
260 _bObstetrics and gynecology clinics of North America
_cSep 2006
300 _a397-411 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAbnormalities, Drug-Induced
650 0 4 _aAnticoagulants
_xadministration & dosage
650 0 4 _aContraindications
650 0 4 _aDermatitis, Allergic Contact
650 0 4 _aFemale
650 0 4 _aFibrinolytic Agents
_xadministration & dosage
650 0 4 _aHemorrhage
_xchemically induced
650 0 4 _aHeparin
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aPregnancy
650 0 4 _aPregnancy Complications, Hematologic
_xdrug therapy
650 0 4 _aThrombocytopenia
_xchemically induced
650 0 4 _aThrombophilia
_xdrug therapy
650 0 4 _aVenous Thrombosis
_xdrug therapy
650 0 4 _aVitamin K
_xantagonists & inhibitors
700 1 _aLissalde-Lavigne, Géraldine
700 1 _aQuére, Isabelle
700 1 _aMarés, Pierre
773 0 _tObstetrics and gynecology clinics of North America
_gvol. 33
_gno. 3
_gp. 397-411
856 4 0 _uhttps://doi.org/10.1016/j.ogc.2006.05.004
_zAvailable from publisher's website
999 _c16546031
_d16546031